In vitro p24 antigen-stimulated lymphocyte proliferation and β-chemokine production in human immunodeficiency virus type 1 (HIV-1) seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune)

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 3, 1998, Pages 308-312

  Moss, Ronald B ^a   Wallace, Mark R ^b   Lanza, Paola ^a   Giermakowska, Wieslawa ^a   Jensen, Fred C ^a   Theofan, Georgia ^a   Chamberlin, Carolyn ^b   Richieri, Steven P ^a   Carlo, Dennis J ^a  

^a Orchestra Therapeutics Inc   (United States)

^b Space and Naval Warfare Systems Center Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN P24; CHEMOKINE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031831896     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.3.308-312.1998     Document Type: Article

References (23)

1. + T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
2. Caruso, A., S. Licenziati, A. D. Canaris, M. Corulli, M. A. De Francesco, A. Cantalamessa, F. Fallacara, S. Fiorentini, A. Balsari, and A. Turano. 1997. T cells from individuals in advanced stages of HTV-1 infection do not proliferate but express activation antigens in response to HIV-1-specific antigens. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:61-69.
3. + T cells. Science 270:1811-1815.
4. 3a.Connick, E., et al. 1998. Abstract LB14. In Proceedings of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, III., 1 to 5 February 1998.
5. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3:533-540.
6. Ferbas, J., et al. 1997. Poster 91. In Proceedings of the Ninth Annual Meeting of the National Cooperative Vaccine Development Groups, Bethesda, Md., 4 to 7 May 1997.
7. Gringeri, A., et al. 1998. Abstract 111. Proceedings of the Institute of Human Virology 1997 Annual Meeting, Baltimore, Md., 15 to 21 September 1997. J. Hum. Virol. 1(2): 129.
8. B and in human immunodeficiency virus-infected men. Proc. Natl. Acad. Sci. USA 84:4994-4998.
9. Krowka, J. F., D. P. Stites, S. Jain, K. S. Steimer, C. George-Nascimento, A. Gyenes, P. J. Barr, H. Hollander, A. R. Moss, J. M. Homsy, et al. 1989. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J. Clin. Invest. 83:1198-1203.
10. Kundu, S. K., D. Katzenstein, F. T. Valentine, C. Spino, B. Efron, and T. Merigan. 1997. Effect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and RNA: relationship to cellular immune responses. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:269-274.
11. Lange, J. M. A. 1997. Current problems and the future of antiretroviral drug trials. Science 276:548-550.
12. Moss, R. B., S. P. Richieri, F. Ferre, A. E. Daigle, R. Traugcr, G. Theofan, W. Giermakowska, P. Lanza, S. Brostoff, D. J. Carlo, and F. C. Jensen. 1997. HIV-1-specific functional immune measurements as markers of disease progression. J. Biomed. Sci. 4:127-131.
13. Moss, R. B., R. J. Trauger, W. K. Giermakowska, J. L. Turner, M. R. Wallace, F. C. Jensen, S. P. Richieri, F. Ferre, A. E. Daigle, C. Duffy, G. Theofan, and D. J. Carlo. 1997. Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on β-chemokine and cytokine production in subjects with HIV-1 infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:343-350.
14. Moss, R. B., W. Giermakowska, P. Lanza, J. L. Turner, M. R. Wallace, F. C. Jensen, G. Theofan, S. P. Richieri, and D. J. Carlo. 1997. Cross clade immune responses after immunization with a whole-killed gp120-depleted HIV-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE™) in seropositive subjects. Viral Immunol. 10(4):221-228.
15. Pal, R., A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. DeVico. 1997. Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278:695-698.
16. Pontesilli, O., M. Carlesimo, A. R. Varani, R. Ferrara, G. D'Offizi, and F. Aiuti. 1994. In vitro lymphocyte proliferative response to HIV-1 p24 is associated with a lack of CD4+ decline. AIDS Res. Hum. Retroviruses 10:113-114.
17. Reddy, M. M., A. Englard, D. Brown, E. Buimovici-Klien, and M. H. Grieco. 1987. Lymphoproliferative responses to human immunodeficiency virus antigen in asymptomatic intravenous drug abusers and in patients with lymphadenopathy or AIDS. J. Infect. Dis. 156:374-376.
18. Revets, H., D. Marissens, S. de Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
19. Rosenberg, E.-S., J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams, and B. D. Walker. 1997. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278:1447-1450.
20. Schnittman, S. M., and L. Fox. 1997. Preliminary evidence for partial restoration of immune function in HIV type 1 infection with potent antiretroviral therapies: clues from the Fourth Conference on Retroviruses and Opportunistic Diseases. AIDS Res. Hum. Retroviruses 13:815-818.
21. Ullum, H., A. C. Lepri, J. Victor, H. Aladdin, A. N. Phillips, J. Gerstoft, P. Skinhøj, and B. K. Pedersen. 1998. Production of β-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1β are associated with a decreased risk of HIV disease progression. J. Infect. Dis. 177:331-336.
22. Wahren, B., L. Morfeldt-Mansson, G. Biberfeld, L. Moberg, A. Sonnerborg, P. Ljungman, A. Werner, R. Kurth, R. Gallo, and D. Bolognesi 1987. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J. Virol. 61:2017-2023.
23. Zarling, J. M., J. W. Eichberg, P. A. Moran, J. McClure, P. Sridhar, and S.-L. Hu. 1987. Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a rccombinant vaccinia virus expressing AIDS virus envelope glycoproteins. J. Immunol. 139:988-990.